13 / 36
• Indicaciones para el hogar
- Evitar factores desencadenantes como contaminantes
intradomiciliarios (calefacción contaminante,
tabaquismo), alérgenos a los cuales el niño esté
sensibilizado y actividad física entre otros.
- Si requirió corticoides sistémicos completar a lo menos
5 días.
- Salbutamol: continuar su uso 2 puff cada 4 horas hasta
ser controlado por su médico.
- Revisar técnica inhalatoria.
- Plan escrito para manejo precoz en domicilio de futuras
exacerbaciones.
- Control por médico especialista en enfermedades
respiratorias, para estudio y seguimiento.
REFERENCIAS
1. Sears MR, Greene JM, William AR, Wiecek EM, Taylor DR, FlanneryEM
et al. A longitudinal, population-based, cohort study of childhood asthma
followed to adulthood. N Engl J Med 2003; 349:1414-1422
2. Phelan PD, Robertson CF y Olinsky A. The Melbourn Asthma Study:
1964-1999. J Allergy Clin Inmunol 2002; 109: 189-194
3. Martinez FD. What have we learned from the Tucson Children´s
Respiratory Study. Paediatr Respir Rev 2002; 3: 193-197
4. Tenero L, Tezza G, Cattazzo E y Piacentini G. Wheezing in preschool
children. Early Hum Dev 2013; 89 Suppl 3: S13-17
5. Castro-Rodríguez JA, Holberg CJ, Wright AL y Martínez FD. A clinical
index to define risk of asthma in young children with recurrent wheezing.
Am J Respir Crit Care Med 2000;162: 1403-6
6. Martinez FD, Wright AL, Taussig L, Holberg CJ, Halonen M y Morgan
WJ. Asthma and wheezing in the first six years of life. N Engl J Med
1995; 332: 133-138
7. Henderson J, Granell R, Heron J, Sherrif A, Simpson A, Woodcock A
et al. Associations of wheezing phenotypes in the first 6 years of life
with atopy, lung function and airway responsiveness in mid- childhood.
Thorax 2008; 63:974-980
8. Sonnappa S, Bastardo CM, Wade A, Saglani S, McKenzie SA, Bush A
et al. Symptom-pattern phenotype and pulmonary function in preschool
wheezers . J Allergy Clin Immunol 2010; 126:519-26
9. Brand P, Baraldi E, Bisgaard, Boner A, Castro-Rodriguez JA, Custovic
A et al. Definition assessment and treatment of wheezing disorders in
preschool children and evidence based approach. Eur Resp J 2008;
32:1096-1110
10. Brand P, Caudri D, Eber E, Gaillard E A, Garcia-Marcos L, Hedlin G et
al. Classification and pharmacological treatment of preschool wheezing:
changes since 2008. Eur Respir J 2014; 43: 1172-1177
11. Papadopoulus NG, Arakawa H, Carlsen KH, Custovic A, Gern J,
Lemanske R et al. International consensus on pediatric asthma. Allergy
2012; 67: 976-997
12. Bush A. Diagnosis of asthma in children under five. Prim Care Respir
J 2007; 16:7-15
13. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HG, Aurora P et
al. An Official American Thoracic Society/European Respiratory Society
Statement: Pulmonary Function Testing in Preschool Children. Am J
Respir Crit Care Med 2007; 175:1304-1345
14. Rosenfeld M, Allen J, Arets BH, Aurora P, Beydon N, Calogero C
et al. An Official American Thoracic Society Workshop Report: Optimal
Lung Function Tests for Monitoring Cystic Fibrosis, Bronchopulmonary
Dysplasia and Recurrent Wheezing in Children Less Than 6 years of age.
Ann Am Thorac Soc 2013; 10: S1-S11
15. Kaditis AG, Winnie G, Syrogiannopulos GA. Anti-Inflammatory
Pharmacotherapy for Wheezing in Preschool Children. Pediatr Pulmonol
2007; 42: 407–420
16. Castro-Rodriguez JA y Rodrigo G. Efficacy of inhaled corticosteroids
in infants and preschoolers with recurrent wheezing and asthma: a
systematic review with meta-analysis. Pediatrics 2009;123:e519–e525
17. Guilbert T, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler
SJ et al. Long-Term Inhaled Corticosteroids in Preschool Children at
High Risk for Asthma. NEJM 2006; 354: 1985-97
18. Bacharier L, Guilbert T, Zeiger R, Strunk R, Morgan W, Lemanske R et
al. Patient characteristics associated with improved outcomes with use
of an inhaled corticosteroid in preschool children at risk for asthma. J
Allergy Clin Immunol 2009;123:1077-82
19. Ducharme FM, Lemire C, Noya FJ, Davis GM, Alos N, Leblond H, et
al. Preemptive use of high-dose fluticasone for virus-induced wheezing
in young children. N Engl J Med 2009;360:339-53
20. Bisgaard H, Zielen S, García-García ML, Johnston S, Gilles L, Menten
J et al. Montelukast reduces asthma exacerbations in 2 to 5 year old
children with intermittent asthma. Am J Respir Crit Care Med 2005;
171: 315-322
21. Robertson C, Price D, Henry R, Mellis C, Glasgow N, Fitzgerald D et
al. Short course montelukast for intermittent asthma in children. Am J
Respir Crit Care Med 2007; 175: 323-9
22. Birken CS, Parkin PC y Macarthur C. Asthma severity scores
for preschoolers displayed weaknesses in reliability, validity, and
responsiveness. J Clin Epidemiol 2004; 57:1177-81
23. Chalut DS, Ducharme FM y Davis GM. The Preschool Respiratory
Assessment Measure (PRAM): A responsive index of acute asthma
severity. J Pediatr 2000; 137:762-8
24. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse
WW et al. An official American Thoracic Society/European Respiratory
Society statement: asthma control and exacerbations: standardizing
endpoints for clinical asthma trials and clinical practice. Am J Crit Care
Med 2009; 180:59-99
25. Bekhof J, Reimink R y Brand PL. Systematic review: Insufficient
validation of clinical scores for the assessment of acute dyspnea in
wheezing children. Paediatr Respir Rev 2014; 15: 98-112
26. Ralston M, Hazinski MF, Zaritsky AL, Schexnayder SM, Kleinman ME.
Pediatric Advance Life Support Course Guide. Dallas, TX: American Heart
Association, 2006
27. Carroll W, Lenney W. Drug therapy in the management of acute
asthma. Arch Dis Child Educ Pract Ed 2007;92(3):ep82-6
28. Castro-Rodríguez JA y Rodrigo GJ. Beta-agonists through metered-
dose inhaler with valved holding chamber versus nebulizer for acute
exacerbation of wheezing or asthma in children under 5 years of age:
a systematic review with meta-analysis. J Pediatr 2004; 145:172 -177
29. Douglas G, Higgins B, Barnes N, Boyter A, Burge S, Cates C et al.
British Guideline on the Management of Asthma. Thorax 2008; 63 Suppl
4: 1-121
30. Camargo CA Jr, Rachelefsky, G y Schatz M. Managing asthma
exacerbations in the emergency department: summary of the National
Asthma Education and Prevention Program Expert Panel Report 3
guidelines for the management of asthma exacerbations. J Emerg Med
2009; 37(2 Suppl): S6-S17
31. Ortiz-Alvarez O y Mikrogianakis A. Canadian Paediatric Society.
Acute Care Committee. Managing the paediatric patient with an acute
asthma exacerbation. Paediatr Child Health 2012;17(5):251-62
32. Pedersen SE, Hurd SS, Lemanske RF Jr, Becker A, Zar HJ, Sly PD
et al. Global Initiative for Asthma. Global Strategy for the Diagnosis
and Management of Asthma in Children 5 Years and Younger. Pediatr
Pulmonol. 2011;46 :1-17
33. Papo MC, Frank J y Thompson AE. A prospective, randomized study
of continuous versus intermittent nebulized albuterol for severe status
C o n t e n i d o d i s p o n i b l e e n h t t p : / / www. n e umo l o g i a - p e d i a t r i c a . cl
4 9
Neumol Pediatr 2014; 9 (2): 43-50
Consenso chileno SER-SOCHINEP para el manejo del asma en el pre-escolar